Clinical calculators that do not include demographic variables may be biased, and their equity should be understood in the context of clinical guidelines.
Health systems may be better able to support adoption of chronic care management processes, which have a strong evidence base for practice implementation, compared with patient engagement strategies, which have less evidence to guide effective implementation.
Under preferred pharmacy networks, unsubsidized Part D beneficiaries faced substantial incentives and moderately switched toward preferred pharmacies, whereas subsidized beneficiaries were insulated and demonstrated little switching.
At current costs, the oral bedaquiline-containing regimen for rifampicin-resistant
tuberculosis is unlikely to be cost-effective in many low-income and middle-income
countries. The 6-month regimen represents a cost-effective alternative if injectable
use for 2 months is acceptable.